PDI, Inc. Announces $29 Million in New and Extended Sales Contracts
PARSIPPANY, N.J., July 25, 2012 /PRNewswire/ — PDI, Inc. (Nasdaq: PDII) today announced the signing of several new and extended contracts, including two new wins from Top 10 global pharmaceutical companies. Together the contracts are expected to generate total revenues of $29 million over the lives of the contracts. $12 – $13 million of revenue […]